ArticleWorld journal of gastrointestinal oncology2025
Clinical characteristics and diagnostic factors of tumor-associated acute pancreatitis: A comparative analysis of early
Article in World journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute pancreatitis (AP) is a leading gastrointestinal cause of hospitalization worldwide. While gallstones, alcohol use, and hypertriglyceridemia account for most cases, pancreatic malignancy remains an underdiagnosed but critical etiology requiring prompt identification due to its significant prognostic implications.
aimTo systematically evaluate the clinical characteristics of tumor-associated AP and identify risk factors influencing early diagnosis.
methodsThis retrospective cohort study analyzed 167 patients with pancreatic cancer-associated AP (2014-2023), stratified by diagnostic timing: Early-diagnosis (
resultsThe early-diagnosis group demonstrated distinct clinical and biochemical signatures, with independent predictors including: Diabetes history [odds ratio (OR) = 2.69, 95% confidence interval (CI): 1.08-3.34], concurrent AP etiologies (OR = 4.77, 95%CI: 1.84-7.81), elevated carbohydrate antigen 19-9 (OR = 1.38, 95%CI: 1.03-1.84), hyperbilirubinemia (direct: OR = 2.36, 95%CI: 1.35-3.48; indirect: OR = 2.67, 95%CI: 1.38-4.62), and serum glucose (OR = 1.42, 95%CI: 1.08-2.55).
conclusionKey high-risk indicators for occult pancreatic malignancy in tumor- associated AP patients include: Advanced age, pre-existing diabetes mellitus, hyperbilirubinemia, and concurrent with conventional AP etiologies. These findings advocate for enhanced surveillance protocols incorporating serial tumor markers and multimodal imaging to earlier cancer detection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.